By Aaron Gin — Over the last two months, the United States legislature has introduced three new bills intended to establish a Federal Advisory Committee on the rapidly-evolving field of artificial intelligence (AI) and to analyze and report on the impact and growth of the technology. FUTURE of AI Act On December 12, 2017, Rep. John Delaney (D-MD) and Sen. Maria Cantwell (D-WA) introduced identical bills in the House (as H.R. 4625) and Senate (as S. 2217). The twin bills were entitled the "Fundamentally Understanding The Usability and Realistic Evolution of Artificial Intelligence Act of 2017" — or FUTURE of…Original Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.